We expect the relative contributions of the leasing and direct segments could fluctuate from quarter-to-quarter as equipment upgrades are completed and as the O&O footprint expands. Recent approval from state regulators enable AMS to move forward on planned projects in Rhode Island under its O&O model, a core objective, and AMS anticipates significant synergies within its expanding Rhode Island footprint. In 1Q25, AMS acquired property in Bristol, RI where it expects to construct a linear accelerator facility that would likely begin treating patients in about 18-24 months.
